Search

Roche Holding AG

Închisă

SectorSănătate

278.6 -0.14

Rezumat

Modificarea prețului

24h

Curent

Minim

273.4

Maxim

280

Indicatori cheie

By Trading Economics

Venit

6.3B

Vânzări

31B

P/E

Medie Sector

26.169

57.333

Randament dividend

3.6

Marjă de profit

20.347

Angajați

103,249

EBITDA

11B

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.60%

2.63%

Statistici piață

By TradingEconomics

Capitalizare de piață

205B

Deschiderea anterioară

278.74

Închiderea anterioară

278.6

Roche Holding AG Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 apr. 2025, 07:30 UTC

Câștiguri

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 apr. 2025, 05:31 UTC

Câștiguri

Roche Sales Rise Boosted By Key Drugs

9 apr. 2025, 09:39 UTC

Principalele dinamici ale pieței

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12 mar. 2025, 09:23 UTC

Principalele dinamici ale pieței

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30 ian. 2025, 09:36 UTC

Câștiguri

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30 ian. 2025, 06:32 UTC

Câștiguri

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

24 apr. 2025, 09:39 UTC

Market Talk
Câștiguri

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 apr. 2025, 09:24 UTC

Market Talk
Câștiguri

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 apr. 2025, 09:18 UTC

Market Talk
Câștiguri

Roche's Results Are Solid -- Market Talk

24 apr. 2025, 05:16 UTC

Top știri

Roche Sales Rise, Boosted By Key Drugs

22 apr. 2025, 10:51 UTC

Top știri

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 apr. 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 apr. 2025, 10:03 UTC

Market Talk
Câștiguri

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9 apr. 2025, 07:23 UTC

Market Talk

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 apr. 2025, 08:41 UTC

Market Talk

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 apr. 2025, 07:51 UTC

Market Talk

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31 mar. 2025, 09:31 UTC

Acțiuni populare

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13 mar. 2025, 07:46 UTC

Market Talk

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12 mar. 2025, 16:34 UTC

Top știri

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12 mar. 2025, 08:51 UTC

Market Talk

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12 mar. 2025, 08:18 UTC

Market Talk

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13 feb. 2025, 11:43 UTC

Market Talk

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30 ian. 2025, 07:56 UTC

Market Talk
Câștiguri

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30 ian. 2025, 06:04 UTC

Câștiguri

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

30 ian. 2025, 06:04 UTC

Câștiguri

Roche Expects 2025 Sales Increase in Mid Single Digit Range at Constant Currency

30 ian. 2025, 06:04 UTC

Câștiguri

Roche Issues 2025 View

30 ian. 2025, 06:03 UTC

Câștiguri

Roche Raises Dividend to CHF9.70 Vs CHF9.60

30 ian. 2025, 06:03 UTC

Câștiguri

Roche 2024 Core Operating Profit CHF20.82B

30 ian. 2025, 06:03 UTC

Câștiguri

Roche 2024 Net Pft CHF9.19B

30 ian. 2025, 06:02 UTC

Câștiguri

Analysts Saw 2024 Core EPS at CHF18.59

Roche Holding AG Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.